Wednesday 24 April 2013

Why Tivozanib Deserves FDA Approval

Tivozanib is a new type of anticancer agent that selectively targets the VEGF receptors and has demonstrated useful clinical activity in Phase 3 trials against kidney cancer. Tivozanib is being developed by AVEO pharmaceuticals in partnership with Astellas, the company that partnered Medivation in the devlopment of Xtandi. What sets Tivozanib apart from other VEGFR inhibitors is that it targets all three isoforms providing complete receptor blockade. Targetting VEGF signalling has already led to successful anticancer therapies such as Avastin.

Since VEGF signalling is involved with the growth and spread of metastases VEGFR inhibitors have potential for treating all types of solid tumours that are prone to metastasis such as lung cancer, breast cancer, and prostate cancer. The potential utility of Tivozanib in treating prostate cancer has been somewhat overlooked and no clinical trials have been started yet, but this drug would make a good combination with Zytiga (i.e. Tivozanib Zytiga Combo) for treating metastatic prostate cancer, since both drugs are well tolerated and would combine well together. The VEGFR-2 inhibitor Cabozantinib in combination with Zytiga is currently in clinical trials and the results against resolution of bone mets look impressive.

Molecular structure of Tivozanib shows that it is a very well designed drug. The quinazoline group mimics adenosine and binds into the ATP binding site of the VEGF receptor with the chloroary side chain fitting into the hydrophobic binding pocket.


The next generation of potential blockbusters in oncology will come from the new "inibs", tyrosine kinase inhibitors that are targetted against specific kinases involved in cancer survival. This new generation of oncology drugs includes Ibrutinib (PCYC), Cabozantinib (EXEL), and Tivozanib (AVEO), all of which are showing exciting clinical activity. The first generation of "inibs" are already blockbusters such as Imatinib otherwise known as Glivec (NVS).

The Phase 3 clinical trials of Tivozanib are against kidney cancer, and compared this drug with the current VEGFR inhibitor Sorafenib. There was no increase in overall survival (OS) with patients treated with Tivozanib compared with Sorafenib, but there was a statistically significant increase in progression free survival (PFS) which was the primary goal of the trial. This trial also demonstrated the safety of Tivozanib which showed that it was a well tolerated drug with few side effects and importantly had an improved safety profile when compared to Sorafenib.

Taken together the improvement in progression free survival and good safety profile of Tivozanib make this a useful agent in oncology for treating kidney cancer and warrants regulatory approval.

1 comment:

  1. My name is hoover, my 18 year old daughter, Tricia was diagnosed with herpes 3 years ago. Since then, we have moved from one hospital to another. We tried all kinds of pills, but every effort to get rid of the virus was futile. The bubbles continued to reappear after a few months. My daughter was using 200mg acyclovir pills. 2 tablets every 6 hours and 15g of fusitin cream. and H5 POT. Permanganate with water to be applied twice a day, but all still do not show results. So, I was on the internet a few months ago, to look for other ways to save my only son. Only then did I come across a comment about the herbal treatment of Dr Imoloa and decided to give it a try. I contacted him and he prepared some herbs and sent them, along with guidance on how to use them via the DHL courier service. my daughter used it as directed by dr imoloa and in less than 14 days, my daughter recovered her health. You should contact dr imoloa today directly at his email address for any type of health problem; lupus disease, mouth ulcer, mouth cancer, body pain, fever, hepatitis ABC, syphilis, diarrhea, HIV / AIDS, Huntington's disease, back acne, chronic kidney failure, addison's disease, chronic pain, Crohn's pain, cystic fibrosis, fibromyalgia, inflammatory Bowel disease, fungal nail disease, Lyme disease, Celia disease, Lymphoma, Major depression, Malignant melanoma, Mania, Melorheostosis, Meniere's disease, Mucopolysaccharidosis, Multiple sclerosis, Muscular dystrophy, Rheumatoid arthritis Alzheimer's disease, parkinson's disease, vaginal cancer, epilepsy Anxiety Disorders, Autoimmune Disease, Back Pain, Back Sprain, Bipolar Disorder, Brain Tumor, Malignant, Bruxism, Bulimia, Cervical Disc Disease, Cardiovascular Disease, Neoplasms , chronic respiratory disease, mental and behavioral disorder, Cystic Fibrosis, Hypertension, Diabetes, Asthma, Autoimmune inflammatory media arthritis ed. chronic kidney disease, inflammatory joint disease, impotence, alcohol spectrum feta, dysthymic disorder, eczema, tuberculosis, chronic fatigue syndrome, constipation, inflammatory bowel disease. and many more; contact him at drimolaherbalmademedicine@gmail.com./ also with whatssap- + 2347081986098.

    ReplyDelete